SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic
INTC 45.51+10.7%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Flair who wrote (11953)10/22/1997 3:01:00 AM
From: Sonki  Read Replies (2) of 27012
 
flair, thx for news on pfe, vvus, sunw cymi.. nice summary(PFE) 71 +4 3/16: pharmaceutical concern says that Vigra drug for the treatment for erectile dysfunction will receive priority review from the FDA; company submitted the
NDA application on Monday, September 29 and FDA has up to 60 days to formally accept the application.....

listening to msft call.

flair ...pfe will take 1-2 yrs before it can compete w. vvus.
also, slightly different. oral vs. injected.
oral has side effects all over blood stream.
injection gives doctors repeat business.

i m long pfe, but vvus's problem is not pfe but ability to produce.

flair, are u on west coast?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext